Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

In8Bio Inc (INAB)

In8Bio Inc (INAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,466
  • Shares Outstanding, K 10,914
  • Annual Sales, $ 0 K
  • Annual Income, $ -30,010 K
  • EBIT $ -32 M
  • EBITDA $ -30 M
  • 60-Month Beta -0.07
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.74
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.75
  • Most Recent Earnings $-0.15 on 11/12/24
  • Next Earnings Date 11/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.08
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +71.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2621 +15.91%
on 10/31/24
0.4100 -25.90%
on 11/04/24
-0.0062 (-2.00%)
since 10/25/24
3-Month
0.2170 +40.00%
on 10/08/24
0.5881 -48.34%
on 08/26/24
-0.2312 (-43.21%)
since 08/23/24
52-Week
0.2170 +40.00%
on 10/08/24
2.4800 -87.75%
on 12/15/23
-0.4262 (-58.38%)
since 11/24/23

Most Recent Stories

More News
IN8bio Announces Promising Phase 1 Trial Results for INB-200 in Glioblastoma Patients, Highlighting Enhanced Survival and Immune Response

INB-200 trial shows promising survival and immune response in glioblastoma patients, highlighting potential as innovative therapy.Quiver AI SummaryIN8bio, Inc. has reported promising results from its Phase...

INAB : 0.3038 (-4.35%)
IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) Annual Meeting

INAB : 0.3038 (-4.35%)
IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

INAB : 0.3038 (-4.35%)
IN8bio Announces Plenary Oral Presentation at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting

INAB : 0.3038 (-4.35%)
IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting

INAB : 0.3038 (-4.35%)
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June

/PRNewswire/ -- USA News Group - With this year's Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days away, there's...

ONC.TO : 1.31 (-1.50%)
ONCY : 0.9350 (-2.00%)
JAZZ : 124.34 (-1.84%)
GERN : 4.10 (+0.74%)
INAB : 0.3038 (-4.35%)
VCYT : 41.10 (+3.81%)
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:JAZZ),(NASDAQ:GERN),(NASDAQ:INAB),(NASDAQ:VCYT) EQNX::TICKER_END

ONCY : 0.9350 (-2.00%)
ONC.TO : 1.31 (-1.50%)
JAZZ : 124.34 (-1.84%)
GERN : 4.10 (+0.74%)
INAB : 0.3038 (-4.35%)
VCYT : 41.10 (+3.81%)
Significant Oncology Results Set to be Delivered as Oral Presentations at ASCO 2023

USA News Group – With this year’s Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days away, there’s plenty of anticipation for updates on some of the biggest...

ONCY : 0.9350 (-2.00%)
ONC.TO : 1.31 (-1.50%)
JAZZ : 124.34 (-1.84%)
GERN : 4.10 (+0.74%)
INAB : 0.3038 (-4.35%)
VCYT : 41.10 (+3.81%)
IN8bio Observes Durable Morphologic Complete Responses in Ongoing Phase 1 Clinical Trial of INB-100, an Allogeneic Gamma-Delta T Cell Therapy in High-Risk Leukemia Patients

All three patients from the first cohort of high-risk relapsed acute-myeloid leukemia (AML) patients dosed to-date with INB-100 remain alive and...

INAB : 0.3038 (-4.35%)
Newly Issued European Patent Broadens IN8bio’s Drug Resistant Immunotherapy (DRI) Platform

European patent covers any genetic modification conveying chemotherapy resistance to immune cell types, including gamma-delta T cells and now natural...

INAB : 0.3038 (-4.35%)

Business Summary

IN8bio Inc. is a clinical-stage biotechnology company. It focuses on developing therapies for the treatment of cancers, including solid tumors using allogeneic, autologous, and genetically modified gamma-delta T cells. The company's principal candidate includes INB-200, which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 0.3440
2nd Resistance Point 0.3345
1st Resistance Point 0.3191
Last Price 0.3038
1st Support Level 0.2942
2nd Support Level 0.2847
3rd Support Level 0.2693

See More

52-Week High 2.4800
Fibonacci 61.8% 1.6155
Fibonacci 50% 1.3485
Fibonacci 38.2% 1.0815
Last Price 0.3038
52-Week Low 0.2170

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar